IL159622A0 - Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides - Google Patents
Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptidesInfo
- Publication number
- IL159622A0 IL159622A0 IL15962202A IL15962202A IL159622A0 IL 159622 A0 IL159622 A0 IL 159622A0 IL 15962202 A IL15962202 A IL 15962202A IL 15962202 A IL15962202 A IL 15962202A IL 159622 A0 IL159622 A0 IL 159622A0
- Authority
- IL
- Israel
- Prior art keywords
- polypeptides
- factor
- pharmaceutical composition
- factor vii
- vii polypeptides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200101127 | 2001-07-20 | ||
PCT/DK2002/000505 WO2003007983A1 (en) | 2001-07-20 | 2002-07-19 | Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
IL159622A0 true IL159622A0 (en) | 2004-06-01 |
Family
ID=8160632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15962202A IL159622A0 (en) | 2001-07-20 | 2002-07-19 | Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1411973A1 (en) |
JP (1) | JP2004534855A (en) |
KR (1) | KR20040015821A (en) |
CN (1) | CN1304050C (en) |
AU (1) | AU2002354846B2 (en) |
BR (1) | BR0211256A (en) |
CA (1) | CA2452677A1 (en) |
CZ (1) | CZ200439A3 (en) |
HU (1) | HUP0400976A3 (en) |
IL (1) | IL159622A0 (en) |
MX (1) | MXPA04000415A (en) |
NO (1) | NO20040235L (en) |
PL (1) | PL369077A1 (en) |
RU (1) | RU2298416C2 (en) |
WO (1) | WO2003007983A1 (en) |
ZA (1) | ZA200400012B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2378249A1 (en) | 1999-07-14 | 2001-01-25 | Mirella Ezban | Use of fviia or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis |
ES2381110T3 (en) | 2003-09-09 | 2012-05-23 | Novo Nordisk Health Care Ag | Coagulation Factor VII Polypeptides |
CA2540986A1 (en) * | 2003-11-20 | 2005-06-02 | Novo Nordisk Health Care Ag | Therapeutic use of factor xi |
KR20060133575A (en) * | 2004-02-05 | 2006-12-26 | 노보 노르디스크 헬스 케어 악티엔게젤샤프트 | Use of factor viia for treating trauma |
WO2006128497A1 (en) * | 2005-06-01 | 2006-12-07 | Novo Nordisk A/S | Pharmaceutical formulation of factor xi |
BR122021014783B1 (en) | 2008-12-19 | 2023-03-14 | Baxalta GmbH | TFPI-BINDING PEPTIDE, USE OF THE PEPTIDE, PHARMACEUTICAL COMPOSITION AND METHOD FOR PURIFICATION OF TFPI |
AU2011227714B2 (en) | 2010-03-19 | 2014-09-04 | Takeda Pharmaceutical Company Limited | TFPI inhibitors and methods of use |
EP2624859B1 (en) * | 2010-10-06 | 2017-03-01 | Medimmune Limited | Factor ii alone or in combination with further factors for treatment of impaired haemostasis associated with dilutional coagulopathy |
KR102263685B1 (en) | 2012-03-21 | 2021-06-11 | 다케다 야쿠힌 고교 가부시키가이샤 | Tfpi inhibitors and methods of use |
CN105939607A (en) * | 2014-01-31 | 2016-09-14 | 达纳-法伯癌症研究所股份有限公司 | Dihydropteridinone derivatives and uses thereof |
AU2016276963C1 (en) | 2015-06-12 | 2021-08-05 | Dana-Farber Cancer Institute, Inc. | Combination therapy of transcription inhibitors and kinase inhibitors |
US10913752B2 (en) | 2015-11-25 | 2021-02-09 | Dana-Farber Cancer Institute, Inc. | Bivalent bromodomain inhibitors and uses thereof |
US11958911B2 (en) | 2017-02-10 | 2024-04-16 | Shanghai Benemae Pharmaceutical | Anti-coagulation factor XI antibody |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59116213A (en) * | 1982-12-24 | 1984-07-05 | Unitika Ltd | Aerosol composition |
AU593042B2 (en) * | 1985-11-26 | 1990-02-01 | Novo Nordisk Health Care Ag | Compositions and methods for the treatment of bleeding disorders |
US5580560A (en) * | 1989-11-13 | 1996-12-03 | Novo Nordisk A/S | Modified factor VII/VIIa |
FR2676231A1 (en) * | 1991-05-07 | 1992-11-13 | Aetsrn | BLOOD COAGULATION FACTOR XI CONCENTRATE WITH HIGH SPECIFIC ACTIVITY, SUITABLE FOR THERAPEUTIC USE AND ITS PREPARATION PROCESS. |
PL204888B1 (en) * | 2000-09-13 | 2010-02-26 | Novo Nordisk Healthcare Ag | Human coagulation factor vii variants |
-
2002
- 2002-07-19 BR BR0211256-6A patent/BR0211256A/en not_active IP Right Cessation
- 2002-07-19 EP EP02750844A patent/EP1411973A1/en not_active Withdrawn
- 2002-07-19 PL PL02369077A patent/PL369077A1/en not_active Application Discontinuation
- 2002-07-19 CN CNB028185390A patent/CN1304050C/en not_active Expired - Fee Related
- 2002-07-19 AU AU2002354846A patent/AU2002354846B2/en not_active Ceased
- 2002-07-19 JP JP2003513588A patent/JP2004534855A/en active Pending
- 2002-07-19 MX MXPA04000415A patent/MXPA04000415A/en unknown
- 2002-07-19 CZ CZ200439A patent/CZ200439A3/en unknown
- 2002-07-19 IL IL15962202A patent/IL159622A0/en unknown
- 2002-07-19 KR KR10-2004-7000911A patent/KR20040015821A/en not_active Application Discontinuation
- 2002-07-19 WO PCT/DK2002/000505 patent/WO2003007983A1/en not_active Application Discontinuation
- 2002-07-19 HU HU0400976A patent/HUP0400976A3/en unknown
- 2002-07-19 CA CA002452677A patent/CA2452677A1/en not_active Abandoned
- 2002-07-19 RU RU2004105031/15A patent/RU2298416C2/en not_active IP Right Cessation
-
2004
- 2004-01-05 ZA ZA200400012A patent/ZA200400012B/en unknown
- 2004-01-19 NO NO20040235A patent/NO20040235L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1411973A1 (en) | 2004-04-28 |
PL369077A1 (en) | 2005-04-18 |
AU2002354846B2 (en) | 2007-08-02 |
KR20040015821A (en) | 2004-02-19 |
RU2004105031A (en) | 2005-04-20 |
RU2298416C2 (en) | 2007-05-10 |
WO2003007983A1 (en) | 2003-01-30 |
CA2452677A1 (en) | 2003-01-30 |
NO20040235L (en) | 2004-03-17 |
ZA200400012B (en) | 2004-08-17 |
CZ200439A3 (en) | 2005-03-16 |
HUP0400976A3 (en) | 2006-01-30 |
BR0211256A (en) | 2004-07-27 |
MXPA04000415A (en) | 2004-11-22 |
CN1556710A (en) | 2004-12-22 |
CN1304050C (en) | 2007-03-14 |
HUP0400976A2 (en) | 2004-08-30 |
JP2004534855A (en) | 2004-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS1400025I1 (en) | Phenethanolamine derivatives and pharmaceutical composition containing them | |
HUP0500989A2 (en) | Animicrobial polypeptides and their uses | |
EP1450824A4 (en) | Pharmaceutical composition | |
GB0117057D0 (en) | Pharmaceutical composition | |
GB0108470D0 (en) | Pharmaceutical compositions and their use | |
EP1408896A4 (en) | Pharmaceutical composition | |
HUP0400976A3 (en) | Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides | |
HUP0402318A3 (en) | Pharmaceutical composition comprising cyclosporin and use thereof | |
SI1462455T1 (en) | Ser-Ser-Ser-Arg peptide and medicinal uses thereof | |
IL159872A0 (en) | Gmg-2 polypeptides and their use | |
IL152202A0 (en) | Human kcnq5 polypeptide and pharmaceutical compositions containing the same | |
GB0116107D0 (en) | Pharmaceutical composition | |
EP1379228A4 (en) | (z)-styrylbenzylsulfones and pharmaceutical uses thereof | |
HUP0401985A3 (en) | Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides | |
IL156711A0 (en) | Peptide derivatives and pharmaceutical compositions containing the same | |
IL153176A (en) | Phenylpiperazines and pharmaceutical compositions comprising them | |
IL161523A0 (en) | Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides | |
GB0013503D0 (en) | Pharmaceutical compositions and their uses | |
IL135442A0 (en) | Peptides and pharmaceutical compositions comprising them | |
AU2002340777A1 (en) | Pharmaceutical composition comprising factor vii polypeptides and tafi polypeptides | |
AU2002340784A1 (en) | Pharmaceutical composition comprising factor vii polypeptides and alpha2 -antiplasmin polypeptides | |
AU2002340785A1 (en) | Pharmaceutical composition comprising factor vii polypeptides and aprotinin polypeptides | |
AU2002340781A1 (en) | Pharmaceutical composition comprising factor vii polypeptides and thrombomodulin polypeptides | |
AU2002340782A1 (en) | Pharmaceutical composition comprising factor vii polypeptides and protein s inhibitors | |
AU2002340780A1 (en) | Pharmaceutical composition comprising factor vii polypeptides and protein c inhibitors |